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doi:10.1016/j.fjs.2012.01.004Summary Mesenchymal chondrosarcomas are very rare central nervous system (CNS) tumors
consisting of undifferentiated mesenchymal cells plus islets of cartilage. We report a case of
giant intracranial mesenchymal chondrosarcomas presenting with acute neurologic deteriora-
tion. A 22-year-old woman presented with right facial and hand numbness and ocular torsion
for about 2 weeks. Magnetic resonance imaging (MRI) disclosed a mass in the right middle
cranial fossa with a mass effect. Two days before scheduled surgery, the patient suddenly lost
consciousness and was found to have uncal herniation. At emergency surgery, the tumor was
totally excised. Pathologically, there was a dimorphic pattern of undifferentiated cells and
islets of cartilage, consistent with mesenchymal chondrosarcoma. Although the patient
survived surgery, she remained in a vegetative state. The tumor recurred 3 years after surgery.
Intracranial mesenchymal chondrosarcoma is rare and should be considered when evaluating
a tumor with dural involvement, particularly in younger adults. Differential diagnoses include
intracranial meningioma and schwannoma. An aggressive surgical resection is highly recom-
mended because of the high risk of recurrence.
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Mesenchymal chondrosarcoma is an extremely rare central
nervous system (CNS) tumor. It is a variant of chon-
drosarcoma, itself quite rare and accounting for only 0.16%
of all cranial and intracranial tumors.1 Mesenchymal chon-
drosarcoma, first described by Lightenstein and Bernstein2ciation. Published by Elsevier Taiwan LLC. All rights reserved.
94 H.-S. Lin et al.in 1959, has distinct pathological findings that differentiate
it from classical chondrosarcoma. The tumor comprises two
components: undifferentiated mesenchymal cells and islets
of cartilage.3 We present a case of mesenchymal chon-
drosarcoma and review published reports of this entity.
2. Case report
A 22-year-old woman presented with a 2-week history of
right facial and hand numbness, dizziness, headache,
ocular torsion, and neck pain. She reported a transient
episode of right peripheral facial palsy six months previ-
ously that had subsided spontaneously. On examination,
the patient was alert. The pupils were isochoric with
normal light reflexes. There was no visual field abnormality
by confrontation, but there was right abducens palsy. There
was right facial paresthesia, but the masseter muscles had
full strength bilaterally. There was no facial paralysis,
tongue deviation, or hoarseness.
An outpatient magnetic resonance imaging (MRI) of the
brain showed a large lobulated tumor in the right middle
cranial fossa, causing compression of the right lateral
ventricle and a midline shift to the left. The signal intensity
was isointense to gray matter on T1- and T2-weighted
images. The lesion enhanced strongly after contrast
administration (Fig. 1). The preoperative diagnosis was
Schwannoma or meningioma of the right middle fossa. An
operation was scheduled.
Two days before the scheduled surgery, however, the
patient was brought to the emergency room with severe
headache and fever. She was initially alert but rapidly
deteriorated and had a Glasgow Coma Scale score of
E3M4V1. The pupils were dilated bilaterally and without
light reflex. Brain computed tomography (CT) revealedFigure 1 MRI of intracranial mesenchymal chondrosarcoma.
The tumor is strongly enhanced with contrast (arrow).a lobulated tumor in the right middle cranial fossa with
focal bony erosion of the base of the skull and scattered
calcification within the mass. There was compression of the
right lateral ventricle, right-to-left subfalcine herniation,
and right uncal herniation. Perifocal edema was present
(Fig. 2A).
An emergency decompressive craniectomy of the right
fronto-temporo-parietal region was performed, and an
external ventricular drain was placed. The tumor was dark-
brown, lobulated, and hypervascular. The interface
between brain and tumor was well defined. The tumor and
its dural attachment were totally removed (Fig. 2B). Two
days after the first operation, decompressive craniectomy
was performed contralaterally because of persistently
elevated intracranial pressure.
In pathological study, the tumor was light tan to dark
brown and contained foci of oval-shaped bony tissue
grossly. Microscopically, there were many small vascular
spaces, some with a staghorn pattern. The tumor was
composed of sheets of small, undifferentiated, oval or
spindle-shaped cells and islets of cartilaginous tissue with
foci of central calcification and ossification (Fig. 3). Mitoses
were rare. Areas of necrosis were found. The dimorphic
pattern and the presence of necrosis were consistent with
a diagnosis of mesenchymal chondrosarcoma. In spite of all
our efforts, the patient did not regain consciousness and
remained in a vegetative state postoperatively.
The patient was brought back three years after the first
operation with bulging of the scalp flap at the right cra-
niectomy site. Brain CT revealed local recurrence of the
tumor in the right middle cranial fossa (Fig. 4). Because of
her persistent vegetative state, the family refused further
surgery and other treatment modalities.3. Discussion
Intracranial mesenchymal chondrosarcoma is an extremely
rare CNS tumor. Given the rarity of this tumor, making the
diagnosis and choosing proper management are chal-
lenging. We have reviewed cases reported in the English
literature and updated several earlier literature reviews.
Intracranial mesenchymal chondrosarcoma was initially
thought to arise from bone. However, in nearly half of
reported cases it was extraskeletal, with the meninges
being the most common site of origin.3 Hypotheses about
the pathogenesis posit an origin in embryonal cartilaginous
rests in the skull and dura or from meningeal fibroblasts or
multipotent mesenchymal cells in the dura or arachnoid,4
but the evidence available is inadequate to draw a firm
conclusion.
As noted above, mesenchymal chondrosarcomas have
two basic components. The tumors are highly cellular with
undifferentiated mesenchymal cells, but they also contain
islands of well-differentiated hyaline cartilage.3 The
undifferentiated cells have round to spindle-shaped nuclei
and are randomly arranged in sheets surrounding the
cartilage. This appearance contrasts with classical chon-
drosarcoma, in which cells are usually well-differentiated
with few or no mesenchymal components. Instead, the
cartilaginous element predominates and gradually merges
with the stroma. The microscopic distinction between
Figure 2 (A) Brain CT showing right temporal mass with perifocal edema and uncal herniation. (B) Repeat CT 2 weeks after
surgery.
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difficult. Although the arrangement of undifferentiated
cells of mesenchymal chondrosarcoma closely resembles
that of hemangiopericytoma, the presence of cartilaginous
foci is sufficient to exclude hemangiopericytoma.5,6 If light
microscopic features are equivocal, ultrastructural exami-
nation may be useful in delineating these two entities. In
our case, the light microscopic findings were quite clear
and sufficient to confirm the diagnosis of mesenchymal
chondrosarcoma.
A few years after mesenchymal chondrosarcoma of non-
osseous origin was first described, Dahlin and Henderson7
reported the first case of one occurring intracranially.
Since then, 39 cases have been reported, the largest single
series being that of Rushing et al in 1996 with eight intra-
cranial tumors. Including our case, the 40 patients’ ages
have ranged from 6 months to 68 years (mean 21.2 years),
including 19 who were 15 years old or less. The male-to-
female ratio was 9:11, and the peak incidence was in the
second and third decades. This differs from classical
chondrosarcoma, with a male-to-female ratio of 5:3 and
a peak incidence in the sixth decade.8 The tumor was
attached to the dura in 31 patients, including ours, and wasFigure 3 Tissue sample of resected tumor showing a dimorphic p
surrounding islets of cartilaginous tissue. Foci of calcification are pintraparenchymal in the other nine patients. The high
proportion of cases with dural involvement lends support
to the theory that the tumor originates in multipotent
mesenchymal cells in the dura or arachnoid.6,7 The
outcome varied considerably, with 17 patients dying 3 days
to 9 years (mean 39.7 months) after surgery. The longest
reported survival was 10 years, and that patient died of
a myocardial infarction. Recurrences occurred in 18
patients, ranging from 3 weeks to 3 years after resection.
One patient developed leptomeningeal dissemination, and
3 had distant metastases to the vertebrae,9 ribs,5 or heart
and intra-abdominal organs.10 The wide range in reported
outcome seems to indicate considerable variability in the
natural history of the disease. Of all the reported cases,
ours is the only one with uncal herniation occurring before
surgery.
Recommended treatment for intracranial mesenchymal
chondrosarcoma is radical surgical excision if possible.3,11,12
Preoperative embolization has been suggested because the
tumor is highly vascular.5,13 Recurrence is common after
resection, however. Some authors therefore recommend
adjuvant radiation therapy to prevent recurrence, but it is
difficult to tell if this mode of adjuvant therapy is effectiveattern of sheets of undifferentiated spindle-shaped small cells
resent in cartilage. (H&E.  100).
Figure 4 Brain CT with contrast demonstrating local recur-
rence of the tumor 3 years after surgery.
96 H.-S. Lin et al.for the purpose.3,8,14 Because of the few cases with metas-
tases, adjuvant chemotherapy has also been recommended
regardless of treatment for the primary tumor.12,14,15 Again,
the small number of cases prohibits drawing any conclusions
about such treatment.
4. Conclusions
Intracranial mesenchymal chondrosarcoma should be
considered when evaluating tumors with dural involve-
ment, particularly in young adults. Aggressive surgical
resection is recommended. The value of adjuvant radiation
or chemotherapy is unknown, but given the rarity of the
disease, it is unlikely that these modalities can be rigor-
ously investigated, leaving it to physicians to decide in any
particular case. Regardless of therapy, patients should be
closely monitored after surgery because of the high risk of
recurrence.References
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